Studies investigating metabolic syndrome have consistently found that affected individuals tend to have lower circulating omentin-1 levels compared to healthy controls, a finding that aligns with omentin’s inverse association with body mass index (BMI), triglyceride levels, and insulin resistance [38,39,40]. Here, ITLN1 is linked to metabolic syndrome.